PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Quanterix Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Quanterix Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: For every $100 of sales, $51 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $30 tied up three years earlier. More money tied up than 93% of Healthcare companies in United States.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-13.4×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 54% of Healthcare companies in United States.

Cash Locked Ratio

$51

For every $100 of sales, $51 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $30 tied up three years earlier.

More money tied up than 93% of Healthcare companies in United States.

Growth quality

Steadiness Ratio

3/3 · 1/3

Sales grew in 3 of the last 3 years; profit grew in 1 of 3.

Steadier than 69% of Healthcare companies in United States.

Growth Efficiency Ratio

−$22

Sales grew 32% in 3 years, but profit fell: $22 less profit per $100 of extra sales.

Lower than 77% of Healthcare companies in United States.

Asset Productivity Ratio

+32% / -3%

In 3 years sales changed by +32% while total assets changed by -3%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

-9.8×

Operating cash was negative last year, while some debt falls due within a year.

Higher than 54% of Healthcare companies in United States.

Cash Cushion Ratio

+60%

Cash, after subtracting all debt, equals 60% of its market value (net cash).

Higher than 81% of Healthcare companies in United States.

Tangible Assets Ratio

62%

Of every $100 the company owns, $62 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 68% of Healthcare companies in United States.

Tangible Net Worth Ratio

47%

Of every $100 of net worth, $47 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 54% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+25%

Share count rose 25% in 3 years, so each share's slice of the company became smaller.

Smaller rise in share count than 55% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (12)

Quanterix Corporation made a loss over the last year. Quanterix Corporation owes $0.26 for every $1 it owns. Quanterix Corporation made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Quanterix Corporation made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

0.57

The share price is 0.57 times Quanterix Corporation's book value per share, lower than 90% of Healthcare companies in United States.

Market cap

$134 M

The total market value of all of Quanterix Corporation's shares at today's price (share price × number of shares), smaller than 62% of Healthcare companies in United States. PosiCap size class: Mini Cap.

Net worth (book value)

$237 M

What Quanterix Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$5.02

Net worth divided by the number of shares. The share price of $2.84 is 0.6 times this, which is the P/B above.

Return on equity (ROE)

-46.5%

Quanterix Corporation lost 46.5% of its shareholders' money over the last year, higher than 51% of Healthcare companies in United States.

Owes vs Owns

0.26×

Quanterix Corporation owes $0.26 for every $1 it owns (low), lower than 66% of Healthcare companies in United States.

Dividend yield

None

Quanterix Corporation does not currently pay a dividend.

Revenue growth

+2%

Revenue rose 2% in the year to Dec 2025, and grew 10% a year on average over 3 years.

Profit growth

Loss

Quanterix Corporation made a loss in each of the last two years.

Profit margin

-77.3%

Quanterix Corporation lost $77 for every $100 of revenue.

Cash vs debt

Net cash

Quanterix Corporation held $81 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Quanterix Corporation: $134 M ÷ $237 M (30 Jun 2026) = 0.6.

What is Quanterix Corporation's return on equity?

Quanterix Corporation lost 46.5% of its shareholders' money over the last year, higher than 51% of Healthcare companies in United States.

How much does Quanterix Corporation owe compared with what it owns?

Quanterix Corporation owes $0.26 for every $1 it owns (low), lower than 66% of Healthcare companies in United States.

Does Quanterix Corporation pay a dividend?

No. Quanterix Corporation does not currently pay a dividend.

Is Quanterix Corporation's revenue growing?

Revenue rose 2% in the year to Dec 2025, and grew 10% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.